{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:00:03Z","timestamp":1791990003674,"version":"4.4.0"},"reference-count":142,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.cca.2019.11.012","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T11:46:35Z","timestamp":1573731995000},"page":"198-206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":116,"special_numbering":"C","title":["Bone alkaline phosphatase: An important biomarker in chronic kidney disease \u2013 mineral and bone disorder"],"prefix":"10.1016","volume":"501","author":[{"given":"Adrien","family":"Nizet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0947-2226","authenticated-orcid":false,"given":"Etienne","family":"Cavalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Stenvinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Haarhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2123-7838","authenticated-orcid":false,"given":"Per","family":"Magnusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2019.11.012_b0005","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12291-013-0408-y","article-title":"Alkaline phosphatase: An overview","volume":"29","author":"Sharma","year":"2014","journal-title":"Indian J. Clin. Biochem."},{"key":"10.1016\/j.cca.2019.11.012_b0010","series-title":"Mammalian Alkaline Phosphatases: From Biology to Applications in Medicine and Biotechnology","author":"Mill\u00e1n","year":"2006"},{"key":"10.1016\/j.cca.2019.11.012_b0015","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1359\/jbmr.1997.12.2.210","article-title":"Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor-I (IGF-I) and during growth hormone therapy in adults with growth hormone deficiency","volume":"12","author":"Magnusson","year":"1997","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.cca.2019.11.012_b0020","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/BCO.0b013e3282630851","article-title":"The role of alkaline phosphatase in mineralization","volume":"18","author":"Golub","year":"2007","journal-title":"Curr. Opin. Orthop."},{"key":"10.1016\/j.cca.2019.11.012_b0025","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nrneph.2017.60","article-title":"Alkaline phosphatase: A novel treatment target for cardiovascular disease in CKD","volume":"13","author":"Haarhaus","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.cca.2019.11.012_b0030","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cca.2018.03.009","article-title":"Clinical utility of bone turnover markers in the management of common metabolic bone diseases in adults","volume":"481","author":"Glendenning","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2019.11.012_b0035","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.2215\/CJN.10091110","article-title":"Bone alkaline phosphatase and mortality in dialysis patients","volume":"6","author":"Drechsler","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2019.11.012_b0040","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0378-4347(92)80177-R","article-title":"Determination of alkaline phosphatase isoenzymes in serum by high-performance liquid chromatography with post-column reaction detection","volume":"576","author":"Magnusson","year":"1992","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.cca.2019.11.012_b0045","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1093\/ndt\/gfp300","article-title":"Clinical significance of bone alkaline phosphatase isoforms, including the novel B1x isoform, in mild to moderate chronic kidney disease","volume":"24","author":"Haarhaus","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cca.2019.11.012_b0050","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s00223-001-1137-4","article-title":"Differences in sialic acid residues among bone alkaline phosphatase isoforms: A physical, biochemical, and immunological characterization","volume":"71","author":"Magnusson","year":"2002","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.cca.2019.11.012_b0055","first-page":"453","article-title":"The three dimensional structure of alkaline phosphatase from E. coli","volume":"55","author":"Wyckoff","year":"1983","journal-title":"Adv. Enzymol. Relat. Areas Mol. Biol."},{"key":"10.1016\/j.cca.2019.11.012_b0060","doi-asserted-by":"crossref","first-page":"9158","DOI":"10.1074\/jbc.M009250200","article-title":"Crystal structure of alkaline phosphatase from human placenta at 1.8 \u00c5 resolution","volume":"276","author":"Le Du","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2019.11.012_b0065","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s002239900441","article-title":"Skeletal alkaline phosphatase activity is primarily released from human osteoblasts in an insoluble form, and the net release is inhibited by calcium and skeletal growth factors","volume":"62","author":"Anh","year":"1998","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.cca.2019.11.012_b0070","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0009-8981(01)00584-8","article-title":"Quantitation of soluble and skeletal alkaline phosphatase, and insoluble alkaline phosphatase anchor-hydrolase activities in human serum","volume":"311","author":"Anh","year":"2001","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2019.11.012_b0075","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0009-8981(02)00248-6","article-title":"Different distributions of human bone alkaline phosphatase isoforms in serum and bone tissue extracts","volume":"325","author":"Magnusson","year":"2002","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2019.11.012_b0080","doi-asserted-by":"crossref","first-page":"31171","DOI":"10.1074\/jbc.M102788200","article-title":"Structural evidence for a functional role of human tissue nonspecific alkaline phosphatase in bone mineralization","volume":"276","author":"Mornet","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2019.11.012_b0085","doi-asserted-by":"crossref","first-page":"22781","DOI":"10.1074\/jbc.272.36.22781","article-title":"Mammalian alkaline phosphatases are allosteric enzymes","volume":"272","author":"Hoylaerts","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2019.11.012_b0090","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.bone.2009.07.009","article-title":"Glycosylation differences contribute to distinct catalytic properties among bone alkaline phosphatase isoforms","volume":"45","author":"Halling Linder","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.cca.2019.11.012_b0095","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/bj3210297","article-title":"Human tissue non-specific alkaline phosphatases: sugar-moiety-induced enzymic and antigenic modulations and genetic aspects","volume":"321","author":"Nosjean","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/j.cca.2019.11.012_b0100","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cca.2006.12.024","article-title":"Analysis of human bone alkaline phosphatase isoforms: Comparison of isoelectric focusing and ion-exchange high-performance liquid chromatography","volume":"379","author":"Sharp","year":"2007","journal-title":"Clin. Chim. Acta"},{"issue":"4","key":"10.1016\/j.cca.2019.11.012_b0105","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1172\/JCI117814","article-title":"Alkaline phosphatase: Placental and tissue-nonspecific isoenzymes hydrolyze phosphoethanolamine, inorganic pyrophosphate, and pyridoxal 5\u2019-phosphate. Substrate accumulation in carriers of hypophosphatasia corrects during pregnancy","volume":"95","author":"Whyte","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2019.11.012_b0110","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.14","article-title":"Hypophosphatasia \u2014 aetiology, nosology, pathogenesis, diagnosis and treatment","volume":"12","author":"Whyte","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cca.2019.11.012_b0115","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00223-015-0079-1","article-title":"Alkaline phosphatase and hypophosphatasia","volume":"98","author":"Mill\u00e1n","year":"2016","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.cca.2019.11.012_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbm4.10202","article-title":"How to build a bone: PHOSPHO1, biomineralization and beyond","volume":"3","author":"Dillon","year":"2019","journal-title":"JBMR Plus."},{"key":"10.1016\/j.cca.2019.11.012_b0125","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.7326\/0003-4819-62-6-1234","article-title":"Heat inactivation in the study of human alkaline phosphatases","volume":"62","author":"Posen","year":"1965","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cca.2019.11.012_b0130","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0009-8981(90)90031-M","article-title":"The human alkaline phosphatases: What we know and what we don\u2019t know","volume":"186","author":"Harris","year":"1990","journal-title":"Clin. Chim. Acta."},{"key":"10.1016\/j.cca.2019.11.012_b0135","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0378-4347(00)83881-5","article-title":"Alkaline phosphatase: Laboratory and clinical implications","volume":"429","author":"Meyer-Sabellek","year":"1988","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.cca.2019.11.012_b0140","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0002-9343(74)90631-7","article-title":"Perspectives on alkaline phosphatase isoenzymes","volume":"56","author":"Fishman","year":"1974","journal-title":"Am. J. Med."},{"key":"10.1016\/j.cca.2019.11.012_b0145","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0009-8981(75)90012-1","article-title":"Analysis of heat inactivation curves of alkaline phosphatase isoenzymes in serum","volume":"59","author":"Whitby","year":"1975","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2019.11.012_b0150","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1177\/000456329303000403","article-title":"Multiple forms of human serum alkaline phosphatase: Detection and quantitation","volume":"30","author":"Price","year":"1993","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2019.11.012_b0155","first-page":"1","article-title":"Alkaline phosphatase isoenzymes","volume":"10","author":"Briere","year":"1979","journal-title":"CRC Crit. Rev. Clin. Lab. Sci."},{"issue":"9","key":"10.1016\/j.cca.2019.11.012_b0160","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1136\/jcp.39.9.1025","article-title":"Quantitative method for determining serum alkaline phosphatase isoenzyme activity I. Guanidine hydrochloride: New reagent for selectively inhibiting major serum isoenzymes of alkaline phosphatase","volume":"39","author":"Shephard","year":"1986","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.cca.2019.11.012_b0165","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/clinchem\/30.7.1182","article-title":"Two new methods for separating and quantifying bone and liver alkaline phosphatase isoenzymes in plasma","volume":"30","author":"Rosalki","year":"1984","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2019.11.012_b0170","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1093\/clinchem\/34.9.1853","article-title":"Improved agarose electrophoretic method for separating alkaline phosphatase isoenzymes in serum","volume":"34","author":"Van Hoof","year":"1988","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2019.11.012_b0175","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/clinchem\/36.2.240","article-title":"Liver- and bone-derived isoenzymes of alkaline phosphatase in serum as determined by high-performance affinity chromatography","volume":"36","author":"Anderson","year":"1990","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2019.11.012_b0180","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1006\/abio.1993.1247","article-title":"Methodological aspects on separation and reaction conditions of bone and liver alkaline phosphatase isoform analysis by high-performance liquid chromatography","volume":"211","author":"Magnusson","year":"1993","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.cca.2019.11.012_b0185","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/17453679509157692","article-title":"Determination of bone alkaline phosphatase isoforms in serum by a new high-performance liquid chromatography assay in patients with metabolic bone disease","volume":"66","author":"Magnusson","year":"1995","journal-title":"Acta Orthop."},{"key":"10.1016\/j.cca.2019.11.012_b0190","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00223-015-0088-0","article-title":"Glycation contributes to interaction between human bone alkaline phosphatase and collagen Type I","author":"Halling Linder","year":"2016","journal-title":"Calcif. Tissue Int. 98"},{"key":"10.1016\/j.cca.2019.11.012_b0195","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3109\/00365511003642527","article-title":"Circulating and tissue-derived isoforms of bone alkaline phosphatase in Paget\u2019s disease of bone","volume":"70","author":"Magnusson","year":"2010","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.cca.2019.11.012_b0200","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00223-018-0399-z","article-title":"Alkaline phosphatases in the complex chronic kidney disease-mineral and bone disorders","volume":"103","author":"Bover","year":"2018","journal-title":"Calcif. Tissue Int."},{"issue":"2","key":"10.1016\/j.cca.2019.11.012_b0205","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.bone.2012.12.048","article-title":"Isozyme profile and tissue-origin of alkaline phosphatases in mouse serum","volume":"53","author":"Halling Linder","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.cca.2019.11.012_b0210","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s00467-006-0231-2","article-title":"The novel bone alkaline phosphatase B1x isoform in children with kidney disease","volume":"21","author":"Swolin-Eide","year":"2006","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.cca.2019.11.012_b0215","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1515\/CCLM.2011.621","article-title":"IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37\u00b0C. Part 9: Reference procedure for the measurement of catalytic concentration of alkaline phosphatase International Federation of Clinical Chemistr","volume":"49","author":"Schumann","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2019.11.012_b0220","first-page":"478","article-title":"Quantification and comparison of bone-specific alkaline phosphatase with two methods in normal and paget\u2019s specimens","volume":"3","author":"Masrour Roudsari","year":"2012","journal-title":"Caspian J. Intern. Med."},{"key":"10.1016\/j.cca.2019.11.012_b0225","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1515\/cclm-2016-0605","article-title":"Evaluation of the trueness of serum alkaline phosphatase measurement in a group of Italian laboratories","volume":"55","author":"Braga","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2019.11.012_b0230","series-title":"Methods Enzymol","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/B978-0-12-420070-8.00002-7","article-title":"Quantification of protein concentration using UV absorbance and coomassie dyes","author":"Noble","year":"2014"},{"key":"10.1016\/j.cca.2019.11.012_b0235","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.cca.2012.04.004","article-title":"Evaluation of commutability of several materials for harmonization alkaline phosphatase catalytic concentration measurements","volume":"413","author":"Rami","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2019.11.012_b0240","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1093\/clinchem\/23.12.2263","article-title":"Criteria for establishing a standardized method for determining alkaline phosphatase activity in human serum","volume":"23","author":"Bretaudi\u00e8re","year":"1977","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2019.11.012_b0245","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/00365517409082499","article-title":"Recommended methods for the determination of four enzymes in blood","volume":"33","author":"Keiding","year":"1974","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.cca.2019.11.012_b0250","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1681\/ASN.V73506","article-title":"Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients","volume":"7","author":"Ure\u00f1a","year":"1996","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2019.11.012_b0255","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1515\/CCLM.1998.030","article-title":"Assessment of serum total and bone alkaline phosphatase measurement in clinical practice","volume":"36","author":"Romagnoli","year":"1998","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2019.11.012_b0260","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1093\/clinchem\/44.10.2139","article-title":"Analytical and clinical performance characteristics of Tandem-MP Ostase, a new immunoassay for serum bone alkaline phosphatase","volume":"44","author":"Broyles","year":"1998","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2019.11.012_b0265","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.clinbiochem.2014.04.007","article-title":"Inter-method variability in bone alkaline phosphatase measurement: Clinical impact on the management of dialysis patients","volume":"47","author":"Cavalier","year":"2014","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cca.2019.11.012_b0270","doi-asserted-by":"crossref","unstructured":"J.J. Brady, D. McGoldrick, K. O\u2019Callaghan, F. McNamara, K.J. Mulready, M.R. Cullen, S. Denieffe, M. Fitzgibbon, Bone alkaline phosphatase on the IDS-iSYS automated analyser; cross-reactivity with intestinal ALP, Clin. Chem. Lab. Med. (2018) 12\u201314. doi:10.1515\/cclm-2018-0991.","DOI":"10.1515\/cclm-2018-0991"},{"key":"10.1016\/j.cca.2019.11.012_b0275","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/jclinpath-2014-202766","article-title":"Bone-specific alkaline phosphatase by immunoassay or electrophoresis: Their use in clinical practice","volume":"68","author":"Ahmed","year":"2015","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.cca.2019.11.012_b0280","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0009-8981(97)00052-1","article-title":"Assessment of the performance of a capture immunoassay for the bone isoform of alkaline phosphatase in serum","volume":"263","author":"Milligan","year":"1997","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2019.11.012_b0285","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000067254","article-title":"Monoclonal antibodies against tissue-nonspecific alkaline phosphatase. Report of the ISOBM TD9 workshop","volume":"23","author":"Magnusson","year":"2002","journal-title":"Tumor Biol."},{"key":"10.1016\/j.cca.2019.11.012_b0290","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/clinchem\/41.11.1560","article-title":"Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum","volume":"41","author":"Gomez","year":"1995","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2019.11.012_b0295","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/clinchem\/41.6.853","article-title":"Immunoradiometric method and electrophoretic system compared for quantifying bone alkaline phosphatase in serum","volume":"41","author":"Van Hoof","year":"1995","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2019.11.012_b0300","article-title":"Monoclonal antibody against human bone alkaline phosphatase","volume":"61\u201364","author":"Masuhara","year":"1991","journal-title":"Int. Orthop."},{"key":"10.1016\/j.cca.2019.11.012_b0305","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1272\/jnms.77.4","article-title":"The mechanism of mineralization and the role of alkaline phosphatase in health and disease","volume":"77","author":"Orimo","year":"2010","journal-title":"J. Nippon Med. Sch."},{"key":"10.1016\/j.cca.2019.11.012_b0310","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1210\/en.2003-0717","article-title":"Osteoprotegerin regulates bone formation through a coupling mechanism with bone resorption","volume":"144","author":"Nakamura","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.cca.2019.11.012_b0315","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1042\/bj0170286","article-title":"The possible significance of hexosephosphoric esters in ossification","volume":"17","author":"Robison","year":"1923","journal-title":"Biochem. J."},{"key":"10.1016\/j.cca.2019.11.012_b0320","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1042\/bj0180740","article-title":"The possible significance of hexosephosphoric esters in ossification: Part II. The phosphoric esterase of ossifying cartilage","author":"Robison","year":"1924","journal-title":"Biochem. J. 18"},{"key":"10.1016\/j.cca.2019.11.012_b0325","first-page":"439","article-title":"Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization","volume":"15","author":"Whyte","year":"1994","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cca.2019.11.012_b0330","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1073\/pnas.67.3.1513","article-title":"Isolation and characterization of calcifying matrix vesicles from epiphyseal cartilage","volume":"67","author":"Ali","year":"1970","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cca.2019.11.012_b0335","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/jbmr.435","article-title":"GPM6B regulates osteoblast function and induction of mineralization by controlling cytoskeleton and matrix vesicle release","volume":"26","author":"Drabek","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.cca.2019.11.012_b0340","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1172\/JCI80851","article-title":"Sortilin mediates vascular calcification via its recruitment into extracellular vesicles","volume":"126","author":"Goettsch","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2019.11.012_b0345","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/ki.2012.482","article-title":"Phosphate-induced autophagy counteracts vascular calcification by reducing matrix vesicle release","volume":"83","author":"Dai","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2019.11.012_b0350","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11010-008-9788-3","article-title":"The role of tissue-nonspecific alkaline phosphatase in the phosphate-induced activation of alkaline phosphatase and mineralization in SaOS-2 human osteoblast-like cells","volume":"315","author":"Orimo","year":"2008","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.cca.2019.11.012_b0355","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11302-005-5304-3","article-title":"Physiologic and pathologic functions of the NPP nucleotide pyrophosphatase\/phosphodiesterase family focusing on NPP1 in calcification","volume":"2","author":"Terkeltaub","year":"2006","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.cca.2019.11.012_b0360","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00223-012-9672-8","article-title":"The role of phosphatases in the initiation of skeletal mineralization","volume":"93","author":"Mill\u00e1n","year":"2013","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.cca.2019.11.012_b0365","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0169-6009(92)90750-8","article-title":"The role of alkaline phosphatase in cartilage mineralization","volume":"17","author":"Golub","year":"1992","journal-title":"Bone Miner."},{"key":"10.1016\/j.cca.2019.11.012_b0370","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00223-017-0259-2","article-title":"Bone alkaline phosphatase and tartrate-resistant acid phosphatase: potential co-regulators of bone mineralization","volume":"101","author":"Halling Linder","year":"2017","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.cca.2019.11.012_b0375","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1097\/01.ASN.0000128955.83129.9C","article-title":"Phosphate-induced vascular calcification: Role of pyrophosphate and osteopontin","volume":"15","author":"Lomashvili","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2019.11.012_b0380","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/00365513.2019.1576218","article-title":"Long-term follow-up of biomarkers of vascular calcification after switch from traditional hemodialysis to online hemodiafiltration","volume":"79","author":"Uhlin","year":"2019","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.cca.2019.11.012_b0385","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/jbmr.2606","article-title":"FGF23 regulates bone mineralization in a 1,25(OH) 2 D 3 and klotho-independent manner","volume":"31","author":"Murali","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.cca.2019.11.012_b0390","article-title":"Can serum levels of alkaline phosphatase and phosphate predict cardiovascular diseases and total mortality in individuals with preserved renal function? A systemic review and meta-analysis","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2019.11.012_b0395","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/eci.12752","article-title":"Alkaline phosphatase and prognosis in patients with coronary artery disease","volume":"47","author":"Ndrepepa","year":"2017","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.cca.2019.11.012_b0400","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.bone.2011.01.016","article-title":"Association of bone turnover markers and arterial stiffness in pre-dialysis chronic kidney disease (CKD)","volume":"48","author":"Manghat","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.cca.2019.11.012_b0405","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.lfs.2011.11.006","article-title":"Higher serum bone alkaline phosphatase as a predictor of mortality in male hemodialysis patients","volume":"90","author":"Kobayashi","year":"2012","journal-title":"Life Sci."},{"key":"10.1016\/j.cca.2019.11.012_b0410","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2215\/CJN.12031111","article-title":"Associations of serum skeletal alkaline phosphatase with elevated C-reactive protein and mortality","volume":"8","author":"Filipowicz","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2019.11.012_b0415","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1600-6143.2009.02876.x","article-title":"Markers of the hepatic component of the metabolic syndrome as predictors of mortality in renal transplant recipients","volume":"10","author":"Zelle","year":"2010","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.cca.2019.11.012_b0420","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/10408369409084677","article-title":"Interpretation and clinical significance of alkaline phosphatase isoenzyme patterns","volume":"31","author":"Van Hoof","year":"1994","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.cca.2019.11.012_b0425","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1203\/00006450-199512000-00021","article-title":"Serum osteocalcin and bone and liver alkaline phosphatase isoforms in healthy children and adolescents","volume":"38","author":"Magnusson","year":"1995","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.cca.2019.11.012_b0430","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/cam4.1022","article-title":"Reassessment of alkaline phosphatase as serum tumor marker with high specificity in osteosarcoma","volume":"6","author":"Kim","year":"2017","journal-title":"Cancer Med."},{"key":"10.1016\/j.cca.2019.11.012_b0435","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/adc.57.5.373","article-title":"Plasma alkaline phosphatase activity in rickets of prematurity","volume":"57","author":"Glass","year":"1982","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.cca.2019.11.012_b0440","first-page":"319","article-title":"Serum levels of intact parathyroid hormone and alkaline phosphatase correlate with cortical and trabecular bone loss in primary hyperparathyroidism","volume":"127","author":"Pfeilschifter","year":"1992","journal-title":"Acta Endocrinol. (Copenh)"},{"key":"10.1016\/j.cca.2019.11.012_b0445","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0305-7372(06)80004-6","article-title":"Biochemical markers of bone metabolism in multiple myeloma","volume":"32","author":"Terpos","year":"2006","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.cca.2019.11.012_b0450","first-page":"2056","article-title":"Serum bone alkaline phosphatase isoenzyme levels in normal children and children with growth hormone (GH) deficiency: A potential marker for bone formation and response to GH therapy","volume":"82","author":"Tobiume","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2019.11.012_b0455","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1359\/jbmr.1999.14.11.1926","article-title":"Isoforms of bone alkaline phosphatase: Characterization and origin in human trabecular and cortical bone","volume":"14","author":"Magnusson","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.cca.2019.11.012_b0460","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.2217\/bmm-2018-0089","article-title":"Circulating bone-specific alkaline phosphatase and abdominal aortic calcification in maintenance hemodialysis patients","volume":"12","author":"Yan","year":"2018","journal-title":"Biomark. Med."},{"key":"10.1016\/j.cca.2019.11.012_b0465","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1053\/j.ajkd.2015.02.323","article-title":"Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study","volume":"66","author":"Haarhaus","year":"2015","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cca.2019.11.012_b0470","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1053\/j.ajkd.2013.02.366","article-title":"Bone alkaline phosphatase in CKD-mineral bone disorder","volume":"62","author":"Sardiwal","year":"2013","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cca.2019.11.012_b0475","series-title":"Practical Nephrology","author":"Harber","year":"2014"},{"key":"10.1016\/j.cca.2019.11.012_b0480","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.semnephrol.2014.02.007","article-title":"Laboratory abnormalities in CKD-MBD: markers, predictors, or mediators of disease?","volume":"34","author":"Evenepoel","year":"2014","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.cca.2019.11.012_b0485","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1681\/ASN.2008010014","article-title":"Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients","volume":"19","author":"Regidor","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2019.11.012_b0490","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2215\/CJN.08280813","article-title":"Alkaline phosphatase and mortality in patients on peritoneal dialysis","volume":"9","author":"Liu","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2019.11.012_b0495","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.molmed.2009.07.001","article-title":"Vascular calcification and bone disease: the calcification paradox","volume":"15","author":"Persy","year":"2009","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.cca.2019.11.012_b0500","first-page":"381","article-title":"Calcification vasculaire au cours de l\u2019insuffisance r\u00e9nale chronique: Un ph\u00e9nom\u00e8ne proche de l\u2019ossification endochondrale","volume":"15","author":"Briet","year":"2003","journal-title":"Sang Thromb. Vaiss."},{"key":"10.1016\/j.cca.2019.11.012_b0505","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ki.2008.104","article-title":"Role for alkaline phosphatase as an inducer of vascular calcification in renal failure?","volume":"73","author":"Schoppet","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2019.11.012_b0510","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1681\/ASN.2007080854","article-title":"Mechanisms of vascular calcification in chronic kidney disease","volume":"19","author":"Moe","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2019.11.012_b0515","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1359\/jbmr.080604","article-title":"Annexin-mediated matrix vesicle calcification in vascular smooth muscle cells","volume":"23","author":"Chen","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.cca.2019.11.012_b0520","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/ATVBAHA.117.310578","article-title":"Chronic kidney disease circulating calciprotein particles and extracellular vesicles promote vascular calcification","volume":"38","author":"Viegas","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2019.11.012_b0525","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000346161","article-title":"Calcifying human aortic smooth muscle cells express different bone alkaline phosphatase isoforms, including the novel B1x isoform","volume":"50","author":"Haarhaus","year":"2013","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.cca.2019.11.012_b0530","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/jbmr.2420","article-title":"Pathophysiological role of vascular smooth muscle alkaline phosphatase in medial artery calcification","volume":"30","author":"Sheen","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.cca.2019.11.012_b0535","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/ki.2013.521","article-title":"Vascular calcification is dependent on plasma levels of pyrophosphate","volume":"85","author":"Lomashvili","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2019.11.012_b0540","first-page":"1801","article-title":"Phosphate, pyrophosphate, and vascular calcification: A question of balance","volume":"38","author":"Villa-Bellosta","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cca.2019.11.012_b0545","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.stem.2016.08.001","article-title":"Adventitial MSC-like cells are progenitors of vascular smooth muscle cells and drive vascular calcification in chronic kidney disease","volume":"19","author":"Kramann","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.cca.2019.11.012_b0550","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2337\/dc18-1527","article-title":"Serum uromodulin predicts less coronary artery calcification and diabetic kidney disease over 12 years in adults with type 1 diabetes: the CACTI study","volume":"42","author":"Bjornstad","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2019.11.012_b0555","article-title":"Increased activity of TNAP compensates for reduced adenosine production and promotes ectopic calcification in the genetic disease ACDC","volume":"ra121\u2013ra121","author":"Jin","year":"2016","journal-title":"Sci. Signal."},{"key":"10.1016\/j.cca.2019.11.012_b0560","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1056\/NEJMoa0912923","article-title":"NT5E mutations and arterial calcifications","volume":"364","author":"St Hilaire","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2019.11.012_b0565","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0132822","article-title":"Serum alkaline phosphatase and risk of incident cardiovascular disease: Interrelationship with high sensitivity C-reactive protein","volume":"10","author":"Kunutsor","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2019.11.012_b0570","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/kisup.2013.92","article-title":"Mechanisms of arterial calcifications and consequences for cardiovascular function","volume":"3","author":"London","year":"2013","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.cca.2019.11.012_b0575","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00467-009-1337-0","article-title":"Cardiovascular risk in chronic kidney disease (CKD): The CKD-mineral bone disorder (CKD-MBD)","volume":"25","author":"Hruska","year":"2010","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.cca.2019.11.012_b0580","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/CIRCULATIONAHA.106.678342","article-title":"Chronic kidney disease: effects on the cardiovascular system","volume":"116","author":"Schiffrin","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2019.11.012_b0585","doi-asserted-by":"crossref","first-page":"294","DOI":"10.5551\/jat.RV17020","article-title":"Plaque calcification during atherosclerosis progression and regression","volume":"25","author":"Shioi","year":"2018","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.cca.2019.11.012_b0590","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1359\/jbmr.080610","article-title":"Bone markers predict cardiovascular events in chronic kidney disease","volume":"23","author":"Fahrleitner-Pammer","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.cca.2019.11.012_b0595","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000355807","article-title":"Significant association between bone-specific alkaline phosphatase and vascular calcification of the hand arteries in male hemodialysis patients","volume":"39","author":"Ishimura","year":"2014","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/j.cca.2019.11.012_b0600","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/ndt\/gfp373","article-title":"Age-independent association between arterial and bone remodeling in mild-to-moderate chronic kidney disease","volume":"25","author":"Briet","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cca.2019.11.012_b0605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-35973-5","article-title":"Serum alkaline phosphatase relates to cardiovascular risk markers in children with high calcium-phosphorus product","volume":"8","author":"Xargay-Torrent","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2019.11.012_b0610","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1021\/acschembio.5b00831","article-title":"The Bromodomain: A new target in emerging epigenetic medicine","volume":"11","author":"Smith","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.cca.2019.11.012_b0615","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s40256-018-00315-3","article-title":"How might bromodomain and extra-terminal (BET) inhibitors operate in cardiovascular disease?","volume":"19","author":"Schooling","year":"2019","journal-title":"Am. J. Cardiovasc. Drugs."},{"key":"10.1016\/j.cca.2019.11.012_b0620","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1093\/ndt\/gfy009","article-title":"Targeting epigenetic DNA and histone modifications to treat kidney disease","volume":"33","author":"Fontecha-Barriuso","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cca.2019.11.012_b0625","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/1389557515666150219113205","article-title":"Inhibition of alkaline phosphatase: an emerging new drug target","volume":"15","author":"Al-Rashida","year":"2015","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.cca.2019.11.012_b0630","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1159\/000488257","article-title":"Apabetalone mediated epigenetic modulation is associated with favorable kidney function and alkaline phosphatase profile in patients with chronic kidney disease","volume":"43","author":"Kulikowski","year":"2018","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/j.cca.2019.11.012_b0635","doi-asserted-by":"crossref","first-page":"19754","DOI":"10.1073\/pnas.1310658110","article-title":"RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain","volume":"110","author":"Picaud","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cca.2019.11.012_b0640","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.atherosclerosis.2018.11.002","article-title":"Apabetalone downregulates factors and pathways associated with vascular calcification","volume":"280","author":"Gilham","year":"2019","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.cca.2019.11.012_b0645","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ekir.2017.12.001","article-title":"Benefit of apabetalone on plasma proteins in renal disease","volume":"3","author":"Wasiak","year":"2018","journal-title":"Kidney Int. Rep."},{"issue":"2017","key":"10.1016\/j.cca.2019.11.012_b0650","first-page":"1","article-title":"Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","volume":"7","author":"KDIGO","year":"2017","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.cca.2019.11.012_b0655","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.semnephrol.2014.09.004","article-title":"When, how, and why a bone biopsy should be performed in patients with chronic kidney disease","volume":"34","author":"Ure\u00f1a-Torres","year":"2014","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.cca.2019.11.012_b0660","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.semnephrol.2014.09.008","article-title":"Adynamic bone disease: from bone to vessels in chronic kidney disease","volume":"34","author":"Bover","year":"2014","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.cca.2019.11.012_b0665","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0923-2532(97)87671-5","article-title":"Phosphatases alcalines osseuses et patients en h\u00e9modialyse","volume":"12","author":"Plouvier","year":"1997","journal-title":"Immuno-Analyse Biol. Sp\u00e9cialis\u00e9e."},{"key":"10.1016\/j.cca.2019.11.012_b0670","doi-asserted-by":"crossref","first-page":"17","DOI":"10.11613\/BM.2009.003","article-title":"Biochemical markers of bone remodeling - review","volume":"19","author":"Cepelak","year":"2009","journal-title":"Biochem. Medica."},{"key":"10.1016\/j.cca.2019.11.012_b0675","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s40620-017-0408-8","article-title":"Circulating markers of bone turnover","volume":"30","author":"Vervloet","year":"2017","journal-title":"J. Nephrol."},{"key":"10.1016\/j.cca.2019.11.012_b0680","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0009-9120(97)00113-6","article-title":"Biochemical markers of bone metabolism: an overview","volume":"30","author":"Christenson","year":"1997","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cca.2019.11.012_b0685","first-page":"97","article-title":"Biochemical markers of bone turnover. Part 1: biochemistry and variability","volume":"26","author":"Seibel","year":"2005","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cca.2019.11.012_b0690","series-title":"Biomarkers in Bone Disease","author":"Preedy","year":"2017"},{"key":"10.1016\/j.cca.2019.11.012_b0695","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S2213-8587(17)30184-5","article-title":"Use of bone turnover markers in postmenopausal osteoporosis","volume":"5","author":"Eastell","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.cca.2019.11.012_b0700","doi-asserted-by":"crossref","first-page":"962","DOI":"10.2215\/CJN.11031017","article-title":"Management of osteoporosis in CKD","volume":"13","author":"Khairallah","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2019.11.012_b0705","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.2169\/internalmedicine.8618-16","article-title":"Management of osteoporosis in chronic kidney disease","volume":"56","author":"Nitta","year":"2017","journal-title":"Intern. Med."},{"key":"10.1016\/j.cca.2019.11.012_b0710","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.kint.2017.07.021","article-title":"Fractures in patients with CKD\u2014 diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation","volume":"92","author":"Pimentel","year":"2017","journal-title":"Kidney Int."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898119321254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898119321254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:52:36Z","timestamp":1757861556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898119321254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":142,"alternative-id":["S0009898119321254"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2019.11.012","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone alkaline phosphatase: An important biomarker in chronic kidney disease \u2013 mineral and bone disorder","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2019.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}